Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

New accessible playground opens in Saskatoon

September 11, 2026

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026

Mark Carney meets with ‘Forever Canadian’ campaigners in Banff

September 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Plaintiffs’ Evidence Will Be Heard in Cases Alleging J&J’s Talc Products Caused Women’s Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi
Press Release

Plaintiffs’ Evidence Will Be Heard in Cases Alleging J&J’s Talc Products Caused Women’s Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi

By News RoomJanuary 21, 20263 Mins Read
Plaintiffs’ Evidence Will Be Heard in Cases Alleging J&J’s Talc Products Caused Women’s Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi
Share
Facebook Twitter LinkedIn Pinterest Email

PENSACOLA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — A U.S. District Court Special Master in the talc multidistrict litigation (MDL) against Johnson & Johnson (J&J) entered an Opinion, reaffirming that plaintiffs may present expert testimony supporting general causation to the jury. Specifically, Special Master, Hon. L. Wolfson, former Chief Judge for the District of New Jersey, greenlighted the admissibility of expert testimony supporting that the perineal use of talc can cause ovarian cancer. Throughout her 600-page exhaustive review of the evidence, Judge Wolfson repeatedly emphasized that the issues raised by J&J are issues for juries.

Noting that Judge Wolfson’s Opinion is consistent with the rulings of judges throughout the country, Chris Tisi, Levin Papantonio Partner and Member of the Plaintiff’s Steering Committee for Johnson & Johnson Talcum Powder/Ovarian Cancer (MDL No. 2738), agreed that “It is the role of juries, not corporations, to decide whose science is more credible.   

“This ruling makes clear that Johnson & Johnson cannot keep this case out of the courtroom by attacking credible science,” Tisi added. “The Court recognized that plaintiffs’ experts rely on established methods, real data, and decades of research. At the end of the day, these are factual disputes, and they belong where they always have—with a jury.”

Chris Tisi 2018 (1)

He noted that, in recent months, plaintiffs have prevailed in numerous cases alleging that Johnson’s Baby Powder contained asbestos and caused ovarian cancer and mesothelioma.

In addition to the question of plaintiffs’ core general-causation experts, Judge Wolfson recommended that the Court allow science and geology experts to testify that J&J talc contained trace or ultra-trace asbestos and that historical testing methods, when properly applied, could detect asbestos.

The Court also upheld the notion that plaintiffs’ experts may testify about marketing, regulatory standards, industry practices, and corporate knowledge, including how Defendants’ conduct compared with what was known about talc, asbestos, and ovarian cancer at the time.

Overall, Tisi applauded the Opinion as a positive step forward for women plaintiffs and the U.S. judicial system. While J&J has vowed to appeal Judge Wolfson’s recommendation, Tisi predicts that the appeal will be promptly dismissed and that a federal trial will be set shortly.

“This case is about whether women get to have their injuries evaluated by a jury, or whether a corporation gets to insulate itself by disputing science behind closed doors,” Tisi said. “The Court affirmed that when credible evidence exists, juries—not corporate lawyers—decide responsibility. That principle matters, especially when the health and lives of women are at stake.”

About Levin Papantonio

The Levin Papantonio law firm has been representing injured people worldwide since 1955. The national trial law firm specializes in mass torts, products liability, environmental contamination, drug injuries, and complex personal injury.

Levin Papantonio has gained national recognition as one of the most successful personal injury firms in the world and has been featured on CNN, NBC, ABC, CBS, and Fox, as well as in The Wall Street Journal, The New York Times, The Washington Post, Time Magazine, Forbes, and the National Law Journal.

LP attorneys handle lawsuits throughout the country and have helped obtain more than $80 billion injury verdicts and settlements, litigating against some of the largest corporations in the world.

MEDIA CONTACT:

SARA G. STEPHENS
DIRECTOR, CONTENT & COMMUNICATIONS
LEVIN PAPANTONIO
281-744-6560
[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/4f45ca2a-9425-4651-ad07-39e4bda1e1ba

https://www.globenewswire.com/NewsRoom/AttachmentNg/a6e21ac1-5161-4b97-8756-7acf451ecc43

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

The GLP-1 Boom Is Bypassing Latino Patients; Bilingual Telehealth Clinic Sol y Vida Launches to Change That

California Waste Solutions Approaches 35 Years of Recycling and Global Environmental Infrastructure

“BEYOND THE EXTREME" Digital Music Night Debuts at ICEBAR Stockholm

SALOMON AND IRONMAN ANNOUNCE LONG-TERM PARTNERSHIP, TAKING ENDURANCE WHERE IT GOES NEXT

Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100

HII is Awarded Long-Lead Time Materials Contract for CVN 82

Crypto News Today: MemeToro Leaves Solana and XRP Behind as Presale Moves Toward Stage 7 Sellout

Omniscient Secures Third FDA Clearance, Extending Its Connectomic Platform into the Fast-Growing Deep Brain Stimulation Market

Editors Picks

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026

Mark Carney meets with ‘Forever Canadian’ campaigners in Banff

September 11, 2026

Latest News

Ikea supersized its cheap Bluetooth speaker and added an optical input

September 11, 2026

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

September 11, 2026

Lake Ontario merchandise turns Trump order into fundraiser to protect the lake

September 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version